Nutex Health Inc.
NUTX
$131.90
-$3.58-2.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 879.95M | 875.26M | 981.20M | 792.19M | 624.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 879.95M | 875.26M | 981.20M | 792.19M | 624.28M |
| Cost of Revenue | 434.85M | 403.95M | 415.20M | 359.19M | 294.36M |
| Gross Profit | 445.10M | 471.31M | 565.99M | 433.00M | 329.92M |
| SG&A Expenses | 30.94M | 58.16M | 186.39M | 173.70M | 93.05M |
| Depreciation & Amortization | 20.93M | 20.53M | 20.62M | 20.59M | 19.88M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 486.72M | 482.63M | 622.21M | 553.48M | 407.29M |
| Operating Income | 393.23M | 392.63M | 358.98M | 238.70M | 216.99M |
| Income Before Tax | 250.13M | 244.78M | 327.54M | 201.02M | 181.20M |
| Income Tax Expenses | 57.81M | 64.42M | 64.29M | 41.74M | 35.04M |
| Earnings from Continuing Operations | 192.31 | 180.36 | 263.25 | 159.29 | 146.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -95.94M | -109.57M | -142.68M | -102.94M | -72.48M |
| Net Income | 96.38M | 70.79M | 120.57M | 56.35M | 73.68M |
| EBIT | 393.23M | 392.63M | 358.98M | 238.70M | 216.99M |
| EBITDA | 414.16M | 413.16M | 379.61M | 259.30M | 236.87M |
| EPS Basic | 13.69 | 10.74 | 20.88 | 10.88 | 13.76 |
| Normalized Basic EPS | 18.73 | 16.80 | 10.60 | 4.63 | 8.46 |
| EPS Diluted | 12.89 | 9.70 | 19.44 | 9.96 | 12.84 |
| Normalized Diluted EPS | 18.26 | 16.13 | 9.58 | 3.97 | 7.79 |
| Average Basic Shares Outstanding | 26.76M | 25.43M | 23.58M | 21.98M | 20.95M |
| Average Diluted Shares Outstanding | 27.42M | 26.69M | 25.17M | 23.09M | 22.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |